Craig A. Collard - 19 Apr 2025 Form 4 Insider Report for HERON THERAPEUTICS, INC. /DE/ (HRTX)

Role
Chief Executive Officer, Director
Signature
/s/Kathryn Lester Attorney-in-fact for Craig Collard
Issuer symbol
HRTX
Transactions as of
19 Apr 2025
Net transactions value
$0
Form type
4
Filing time
22 Apr 2025, 09:39:26 UTC
Previous filing
03 Apr 2025
Next filing
02 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HRTX Common Stock Options Exercise +13,796 +3.7% 391,163 19 Apr 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HRTX Restricted Stock Units Options Exercise $0 -13,796 -8.3% $0.000000 151,766 19 Apr 2025 Common Stock 13,796 $0.000000 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock.
F2 The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024).